Stereotaxis, Inc. (STXS)

Market Cap	154.76M
Revenue (ttm)	26.92M
Net Income (ttm)	-25.35M
Shares Out	85.98M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	370,742
Open	1.870
Previous Close	1.880
Day's Range	1.800 - 1.880
52-Week Range	1.660 - 3.290
Beta	1.54
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 3, 2025

About STXS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminat...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Aug 12, 2004
• Employees: 139
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: STXS
• Website: https://www.stereotaxis.com

Financial Performance

In 2024, Stereotaxis's revenue was $26.92 million, an increase of 0.55% compared to the previous year's $26.77 million. Losses were -$25.35 million, 14.9% more than in 2023.